Medtronic Announces Completion of MiniMed Group Share Exchange Offer
Published · Reading time 2 min
اقرأ بالعربيةMedtronic completed its share exchange offer for MiniMed Group, divesting its entire stake of 252.8 million MiniMed shares in exchange for redeeming 55 million of its own common shares.
What this means
This announcement concerns a financial restructuring transaction carried out by Medtronic to fully exit its subsidiary MiniMed Group. In this type of transaction, the parent company offers its shareholders the opportunity to exchange their shares in the parent company for shares in the subsidiary, then uses the redeemed shares to cancel them and reduce the number of outstanding shares. The final allocation ratio reached only 18.3%, meaning demand for the offer significantly exceeded availability, and therefore only a small portion of shares tendered by each shareholder was accepted. This transaction refocuses Medtronic on its core operations and grants MiniMed complete independence.
Details
Medtronic (MDT) announced the completion of the share exchange offer for MiniMed Group, according to the company's filing. The offer and withdrawal rights ended at midnight on October 9, 2026, New York time. **Transaction Details:** Medtronic decided to exchange its entire remaining stake in MiniMed totaling 252.8 million MiniMed common shares in exchange for redeeming 55 million of its own common shares, according to the company's filing. Total Medtronic common shares properly tendered and not withdrawn amounted to 297.5 million shares, while only 55 million shares were accepted. This means the offer was oversubscribed by approximately 5.4 times. **Allocation Ratio:** A final allocation ratio of 18.3% was applied to all properly tendered shares, except for odd-lots totaling 757,890 shares which were not subject to pro-rata allocation, according to the company's filing. **Final Result:** Following completion of the share exchange offer, Medtronic will retain no common shares of MiniMed outstanding, representing a complete separation between the two companies, according to the company's filing.
Sources and verification
We matched every figure against its official source, and the article passed a second, independent review before publication. This content is produced with automated tools under editorial checks.
Information to help you understand, not investment advice